drugset / Trial / NCT06200597
A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single and multiple ascending doses of LAD603 in healthy adult participants in both Part 1 and 2.
Timeline
- Start
- 2023-12-05
- Primary completion
- 2025-05-11
- Completion
- 2025-05-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAD603 | Unknown | — | Subcutaneous |
Indications
No indication recorded.